Ecovyst Q2 2026 Earnings: Volume Growth Supports a Raised Outlook

Ecovyst (NYSE: ECVT) reported Q2 2026 sales of $250.0 million, up 42% from $176.1 million, while diluted EPS from continuing operations increased to $0.10 from $0.04. Adjusted EBITDA rose 27% to $53.1 million, but its margin narrowed as sulfur cost pass-throughs lifted revenue faster than profit. The company also completed the Calabrian acquisition on June 30 and raised its full-year 2026 outlook.

Core earnings data

The results cover the quarter ended June 30, 2026. Because Ecovyst sold its Advanced Materials & Catalysts business on December 31, 2025, that business is classified as discontinued operations for all periods presented; the company’s operating highlights therefore focus on continuing operations.

Higher regenerated and virgin sulfuric acid volumes, favorable contractual pricing, and approximately $55 million of additional sulfur cost pass-through supported revenue growth. Consolidated GAAP net income, including discontinued operations, was $7.9 million, or $0.07 per diluted share, compared with $6.0 million, or $0.05 per diluted share, a year earlier.

Business and product performance

Regenerated sulfuric acid volumes increased as high refinery utilization and favorable alkylate economics supported demand. Ecovyst also cited less customer downtime than in the prior-year quarter.

Virgin sulfuric acid volume grew at a double-digit rate. The increase reflected customer demand and additional volume from the Waggaman sulfuric acid plant acquired in May 2025.

Ecovyst completed its acquisition of the Calabrian sulfur dioxide and related derivatives business on the final day of the quarter. The acquired operation expands the company’s exposure to mining and water treatment, as well as applications such as food processing and pharmaceuticals. Its expected financial contribution is included in second-half guidance rather than cited as a driver of Q2 results.

Sulfur pass-through lifted sales faster than profit

Approximately $55 million of the $73.9 million year-over-year sales increase came from passing higher sulfur costs through to customers. This raised reported selling prices and revenue, but did not produce a proportional increase in profit.

Cost of goods sold grew 47.3%, compared with the 42.0% increase in sales. Consequently, gross profit rose 23.9% while gross margin declined by about 2.9 percentage points. Adjusted EBITDA margin similarly fell to 21.2% from 23.8%.

Volume growth and favorable net pricing still increased adjusted EBITDA by $11.2 million. However, higher manufacturing expenses, general inflation, and transportation costs absorbed part of that benefit.

Profitability, cash flow, and balance sheet

Interest expense declined to $3.5 million from $8.5 million, helping net income from continuing operations grow faster than operating income. Selling, general, and administrative expenses were nearly unchanged at $17.4 million, while other operating expense increased to $13.0 million from $6.8 million. Ecovyst’s non-GAAP reconciliation included $8.1 million of transaction and related costs, up from $1.5 million.

Cash-flow figures were provided for the first six months rather than Q2 alone. Operating cash flow from continuing operations increased to $55.2 million from $25.3 million, primarily because of higher earnings excluding noncash expenses. Adjusted free cash flow improved to $12.8 million from negative $2.4 million.

At June 30, Ecovyst had $87.8 million of cash and $497.1 million of gross debt. Net debt was $409.3 million, and net debt leverage increased to 2.0 times from 1.2 times at the end of 2025. The increase reflected the additional $100 million term loan associated with Calabrian, while the acquired business had not yet contributed adjusted EBITDA to the trailing 12-month calculation.

Available liquidity totaled $176.3 million, consisting of cash and $88.5 million available under the asset-based lending facility. During the first half, Ecovyst repurchased 3.23 million shares for $35.7 million at an average price of $11.07, although it made no repurchases during Q2 itself.

2026 guidance

Ecovyst raised its full-year outlook to incorporate first-half performance and Calabrian’s expected Q3 and Q4 contribution. The company expects Calabrian to add $10 million to $12 million of adjusted EBITDA during the second half. Higher expected sulfur cost pass-through also contributed to the sales guidance increase.

The sales outlook assumes approximately $220 million of sulfur cost pass-through, up from the previous assumption of approximately $155 million. Ecovyst expects positive demand for regenerated acid in the second half, but still anticipates lower year-over-year virgin sulfuric acid sales in Q3 and Q4 because of fewer spot-sale opportunities. The company also remains cautious about softer demand in some industrial applications.

Ecovyst did not provide GAAP reconciliations for its non-GAAP guidance, citing difficulty forecasting certain noncash, nonrecurring, tax, acquisition, disposition, and foreign-exchange items.

Recent insider transactions

Reported insider activity over the preceding six months included 387,408 shares classified as purchases across 14 transactions and one sale totaling 8,450 shares, producing net purchases of 378,958 shares. The detailed records include stock awards and a derivative-security conversion, so the aggregate purchase figure should not be treated as equivalent to open-market buying.

Risks investors should monitor

• Virgin sulfuric acid demand: Ecovyst expects lower year-over-year sales in the second half because of fewer spot opportunities and remains cautious about some industrial applications.
• Margin pressure: Higher sulfur pass-through can expand reported revenue without a proportional profit benefit, while manufacturing, inflation, and transportation costs may continue to affect margins.
• Calabrian integration: The raised outlook assumes a second-half contribution from Calabrian and future synergies, making integration and execution important to achieving the expected benefits.
• Higher acquisition-related leverage: Net debt leverage rose after the additional term loan, while Calabrian had not yet contributed to trailing 12-month adjusted EBITDA. Capital expenditures are also now expected to be higher than previously guided.

Summary

Ecovyst’s Q2 2026 results benefited from higher regenerated and virgin sulfuric acid volumes, favorable pricing, and lower interest expense. Revenue and adjusted EBITDA increased, but margins narrowed because sulfur pass-through and operating costs caused sales to grow faster than profit. The next points to monitor are second-half virgin acid demand, Calabrian’s contribution and integration, and whether improved earnings can support cash generation while leverage and capital spending remain elevated.